CD40 - Overview: B-Cell CD40 Expression by Flow Cytometry, Blood
Evaluating patients for hyper-IgM type 3 (HIGM3) syndrome due to defects in CD40, typically seen in patients less than 10 years Assessing B-cell immune competence in other clinical contexts, including autoimmunity, malignancy, and...
BUPMX - Overview: Buprenorphine and Norbuprenorphine, Chain of Custody, Random, Urine
Monitoring of compliance of buprenorphine therapy Detection and confirmation of the illicit use of buprenorphine Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the...
C5OHU - Overview: C5-OH Acylcarnitine, Quantitative, Random, Urine
Evaluation of patients with an abnormal newborn screen showing elevations of 3-hydroxyisovaleryl-/2-methyl-3-hydroxybutyryl-carnitine
CATN - Overview: Calcitonin, Serum
Aids in the diagnosis and follow-up of medullary thyroid carcinoma Aids in the evaluation of multiple endocrine neoplasia type II and familial medullary thyroid carcinoma This test is not useful for evaluating calcium metabolic...
COKEX - Overview: Cocaine and Metabolite Confirmation, Chain of Custody, Random, Urine
Detecting and confirming drug abuse involving cocaine Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by...
CD279 - Overview: CD279 (PD-1) Immunostain, Technical Component Only
Identification of follicular T helper cells Phenotyping of angioimmunoblastic T-cell lymphoma
CUT - Overview: Copper, Liver Tissue
Diagnosing Wilson disease and primary biliary cirrhosis using liver tissue specimens
CMVM - Overview: Cytomegalovirus (CMV) Antibodies, IgM, Serum
Aiding in the diagnosis of acute infection with cytomegalovirus This test should not be used for screening blood or plasma donors.
FCDSU - Overview: Comprehensive Drug Screen, Umbilical Cord Tissue
Comprehensive Drug Screen, Umbilical Cord Tissue
ECULI - Overview: Eculizumab, Serum
Assessing the response to eculizumab therapy Assessing the need for dose escalation Evaluating the potential for dose de-escalation or discontinuation of therapy in remission states Monitoring patients who need to be above a certain...
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...